Can we predict successful CPAP treatment in upper airways resistance syndrome?

T. Davies, A. Bibby, S. Backway, M. Juniper, A. Kerry, A. Stanton (Swindon, United Kingdom)

Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Session: Have we advanced in the treatment of sleep disordered breathing?
Session type: Thematic Poster Session
Number: 2591
Disease area: Sleep and breathing disorders

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Davies, A. Bibby, S. Backway, M. Juniper, A. Kerry, A. Stanton (Swindon, United Kingdom). Can we predict successful CPAP treatment in upper airways resistance syndrome?. Eur Respir J 2013; 42: Suppl. 57, 2591

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cognitive function was improved after continuous positive airway pressure treatment in obstructive sleep apnea syndrome
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016


Long term effects of compliance with positive airway pressure (PAP) therapy in patients with obesity hypoventilation syndrome (OHS)
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016

Are respiratory events and/or arousals during each sleep stage different by upper airway collapsibility?
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults II: questionnaires, epidemiology and sleep studies
Year: 2015

A case series of CPAP therapy – Who declines treatment?
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014


Nasal inflammation and sleep quality with continuous positive airway pressure (CPAP) therapy in obstructive sleep apnoea
Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Year: 2013

The effect of positive airway pressure therapy on neurocognitive functions, depression and anxiety in obesity hypoventilation syndrome
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016


Effects of co-existing asthma and OSA on objectively measured sleep and systemic inflammation
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015


Does CPAP therapy affect sleep time in patients with obstructive sleep apnea? A prospective study
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016


The effect of continuous positive airway pressure on basal metabolism rate in patients with severe obstructive sleep apnea syndrome
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015



Patients with sleep apnoea(SA) and severe/difficult to treat asthma(SDTA) have worse asthma related clinical outcomes than those with no sleep apnoea
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016

Treatment of concomitant obstructive sleep apnea/hypopnea syndrome in patients with persistent poorly controlled bronchial asthma - Real opportunity to improve asthma control
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015


Maximum pressures from auto-CPAP devices predict oral appliance treatment success in non-adherent obstructive sleep apnoea patients
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016

Hypertension among obstructive sleep apnea patients compared to controls. Two year change after starting treatment with CPAP
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013

Optimal pressure determination for CPAP in the treatment of obstructive sleep apnea syndrome (OSAS). Comparison of prediction equations and autoCPAP titration
Source: Annual Congress 2013 –Twist in the tale: treating sleep disordered breathing - new technologies, new techniques
Year: 2013


Single center experience of selective upper airway stimulation in 45 patients with obstructive sleep apnea
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016


The efficacy of oral appliance in patients with severe obstructive sleep apnea
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014

Does CPAP treatment lead to gastroesophageal reflux in moderate and severe OSA cases?
Source: International Congress 2014 – Sleep disordered breathing 1
Year: 2014

HFNC: A new therapeutic approach in patients with chronic heart failure and Cheyne-Stokes breathing
Source: International Congress 2016 – Non-CPAP in obstructive and central sleep apnoea and obesity hypoventilation syndrome
Year: 2016


Effect of nasal CPAP on nasal symptoms in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Year: 2013

Performance assessment of a novel medical device for home monitoring of CPAP treatment in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2013 –Twist in the tale: treating sleep disordered breathing - new technologies, new techniques
Year: 2013